SCHEMBL7675702

SCHEMBL7675702

Cc1c(C(=O)NN)[nH]c2ccccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.63
ALDH1A1 P00352 7/20 0.59
HSD17B10 Q99714 3/20 0.59
MAPT P10636 5/20 0.58
KDM4E B2RXH2 5/20 0.58
HPGD P15428 2/20 0.55
USP2 O75604 1/20 0.55
HTT P42858 1/20 0.55
HDAC3 O15379 1/20 0.52
HDAC1 Q13547 1/20 0.52
MAOA P21397 1/20 0.51
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
CAPN1 P07384 1/20 0.48
GFER P55789 1/20 0.48
DAO P14920 1/20 0.47
DDO Q99489 1/20 0.47
AHR P35869 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7338590 0.85 ALDH1A1 (0.56) ALDH1A1HSD17B10MAPTKDM4EHPGD
SCHEMBL30595729 0.85 ALDH1A1 (0.56) ALDH1A1HSD17B10MAPTKDM4EHPGD
SCHEMBL5970635 0.81 MCL1 (0.55) GAAALDH1A1HSD17B10MAPTKDM4E
SCHEMBL6846657 0.81 GAA (0.65) GAAALDH1A1HSD17B10MAPTKDM4E
SCHEMBL4493831 0.81 MAP2 (0.60) ALDH1A1HSD17B10MAPTKDM4EHPGD
SCHEMBL29897041 0.80 ALDH1A1 (0.63) GAAALDH1A1HSD17B10MAPTKDM4E
SCHEMBL2399274 0.80 ALDH1A1 (0.63) GAAALDH1A1HSD17B10MAPTKDM4E
SCHEMBL2722021 0.80 ALDH1A1 (0.63) GAAALDH1A1HSD17B10MAPTKDM4E
SCHEMBL6014809 0.80 GAA (0.63) GAAALDH1A1MAPTKDM4EMEN1
SCHEMBL7675599 0.80 GAA (0.63) GAAALDH1A1MAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors ABBOTT LABORATORIES 2002-07-11 US disclosed
US-6323228-B1 INHIBITING ANGIOGENESIS IN A MAMMAL IN RECOGNIZED NEED OF SUCH TREATMENT COMPRISING ADMINISTERING TO THE MAMMAL WITH INDOLE SUBSTITUTED WITH HYDRAZIDES ABBOTT LABORATORIES 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091148-A1 3-substituted indole antiproliferative angiogenesis inhibitors MKI67, FLT4, IDO1 GAA 3668/4885ALDH1A1 98/4885HSD17B10 1301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.